Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

View source ↗

Summary

A clinical trial sponsored by NINDS is investigating clinical, molecular, and imaging biomarkers in Spinal and bulbar muscular atrophy (Kennedy's disease). The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Spinal and Bulbar Muscular Atrophy, Kennedys Disease | Status: RECRUITING